Literature DB >> 22138034

Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes with oligonucleotides.

Kariem Ezzat1, Henrik Helmfors, Oana Tudoran, Carmen Juks, Staffan Lindberg, Kärt Padari, Samir El-Andaloussi, Margus Pooga, Ulo Langel.   

Abstract

Cell-penetrating peptides (CPPs) are short cationic peptides that penetrate cells by interacting with the negatively charged plasma membrane; however, the detailed uptake mechanism is not clear. In contrary to the conventional mode of action of CPPs, we show here that a CPP, PepFect14 (PF14), forms negatively charged nanocomplexes with oligonucleotides and their uptake is mediated by class-A scavenger receptors (SCARAs). Specific inhibitory ligands of SCARAs, such as fucoidin, polyinosinic acid, and dextran sulfate, totally inhibit the activity of PF14-oligonucleotide nanocomplexes in the HeLa pLuc705 splice-correction cell model, while nonspecific, chemically related molecules do not. Furthermore, RNA interference (RNAi) knockdown of SCARA subtypes (SCARA3 and SCARA5) that are expressed in this cell line led to a significant reduction of the activity to <50%. In line with this, immunostaining shows prevalent colocalization of the nanocomplexes with the receptors, and electron microscopy images show no binding or internalization of the nanocomplexes in the presence of the inhibitory ligands. Interestingly, naked oligonucleotides also colocalize with SCARAs when used at high concentrations. These results demonstrate the involvement of SCARA3 and SCARA5 in the uptake of PF14-oligonucleotide nanocomplexes and suggest for the first time that some CPP-based systems function through scavenger receptors, which could yield novel possibilities to understand and improve the transfection by CPPs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138034     DOI: 10.1096/fj.11-191536

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  35 in total

1.  Cell-Penetrating Peptides Delivering siRNAs: An Overview.

Authors:  Luca Falato; Maxime Gestin; Ülo Langel
Journal:  Methods Mol Biol       Date:  2021

2.  Oligonucleotide therapies for disorders of the nervous system.

Authors:  Olga Khorkova; Claes Wahlestedt
Journal:  Nat Biotechnol       Date:  2017-02-27       Impact factor: 54.908

Review 3.  Cell-penetrating peptides as tools to enhance non-injectable delivery of biopharmaceuticals.

Authors:  Mie Kristensen; Hanne Mørck Nielsen
Journal:  Tissue Barriers       Date:  2016-04-18

Review 4.  A role for peptides in overcoming endosomal entrapment in siRNA delivery - A focus on melittin.

Authors:  Kirk K Hou; Hua Pan; Paul H Schlesinger; Samuel A Wickline
Journal:  Biotechnol Adv       Date:  2015-05-27       Impact factor: 14.227

5.  PepFect14 Signaling and Transfection.

Authors:  Luca Falato; Maxime Gestin; Ülo Langel
Journal:  Methods Mol Biol       Date:  2022

6.  Efficient Peptide-Mediated In Vitro Delivery of Cas9 RNP.

Authors:  Oskar Gustafsson; Julia Rädler; Samantha Roudi; Tõnis Lehto; Mattias Hällbrink; Taavi Lehto; Dhanu Gupta; Samir El Andaloussi; Joel Z Nordin
Journal:  Pharmaceutics       Date:  2021-06-14       Impact factor: 6.321

Review 7.  Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles.

Authors:  Jeremy P Bost; Hanna Barriga; Margaret N Holme; Audrey Gallud; Marco Maugeri; Dhanu Gupta; Taavi Lehto; Hadi Valadi; Elin K Esbjörner; Molly M Stevens; Samir El-Andaloussi
Journal:  ACS Nano       Date:  2021-09-10       Impact factor: 15.881

8.  Epidermal SR-A Complexes Are Lipid Raft Based and Promote Nucleic Acid Nanoparticle Uptake.

Authors:  Qian Song; Xiao-Qi Wang; Thomas R Holmes; Michael Bonkowski; Eric W Roth; Adam Ponedal; Chad Mirkin; Amy S Paller
Journal:  J Invest Dermatol       Date:  2020-12-30       Impact factor: 7.590

9.  HSV-1 exploits the innate immune scavenger receptor MARCO to enhance epithelial adsorption and infection.

Authors:  Daniel T MacLeod; Teruaki Nakatsuji; Kenshi Yamasaki; Lester Kobzik; Richard L Gallo
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA.

Authors:  Peter Järver; Thibault Coursindel; Samir El Andaloussi; Caroline Godfrey; Matthew Ja Wood; Michael J Gait
Journal:  Mol Ther Nucleic Acids       Date:  2012-06-12       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.